Evidence-based dry-eye therapies for clinical use

CPD
1
8 October 2021
Volume 22, Issue 3

This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.

Domains covered

Professionalism Clinical practice Specialty CPD (IP)

Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Speaker: Mandy Davidson BSc MCOptom

Adrian O’Dowd asks if the growing use of topography in community optometry will lead to wavefront analysis gaining traction as a complementary tool.

New research has found links between the severity of visual impairment and the risk of dementia. Kathy Oxtoby asks: how can optometrists play a greater role in supporting patients with these conditions?